C21 Investments Inc. (CXXIF)
OTCMKTS · Delayed Price · Currency is USD
0.3700
+0.0150 (4.23%)
Aug 21, 2025, 3:21 PM EDT
C21 Investments Market Cap
C21 Investments has a market cap or net worth of $41.63 million as of August 21, 2025. Its market cap has increased by 29.81% in one year.
Market Cap
41.63M
Enterprise Value
51.69M
Revenue
32.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.37
Market Cap Chart
Since September 7, 1988, C21 Investments's market cap has increased from 6.40M to 41.63M, an increase of 550.53%. That is a compound annual growth rate of 5.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 41.63M | 72.05% |
| Dec 31, 2024 | 24.20M | -16.82% |
| Dec 29, 2023 | 29.09M | 26.13% |
| Dec 30, 2022 | 23.06M | -61.60% |
| Dec 31, 2021 | 60.05M | -59.92% |
| Dec 31, 2020 | 149.82M | 219.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 614.68M |
| Glass House Brands | 595.63M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 375.77M |
| CytoDyn | 360.07M |